Jay L. Alberts, Ph.D. - US grants
Affiliations: | 2000 | Arizona State University, Tempe, AZ, United States |
Area:
Motor controlWe are testing a new system for linking grants to scientists.
The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.
High-probability grants
According to our matching algorithm, Jay L. Alberts is the likely recipient of the following grants.Years | Recipients | Code | Title / Keywords | Matching score |
---|---|---|---|---|
1999 | Alberts, Jay L | R43Activity Code Description: To support projects, limited in time and amount, to establish the technical merit and feasibility of R&D ideas which may ultimately lead to a commercial product(s) or service(s). |
Force Measurement and Analysis System @ Neuroscript, Llc Fast and accurate assessment of motor control has lacked methods to quickly assess force control in movement coordination patterns in everyday tasks. Recent advances in technology and motor research allow us to measure and analyze forces with great reliability. In this proposal we will build a prototype of a user-friendly force measurement and analysis system that provides a fast, objective and quantitative description of movement patterns associated with grip and load forces involved in prehension tasks. The proposed system will be based upon recent findings in motor control and signal processing. It will be one of the first systems providing a comprehensive assessment of the forces used to control and manipulate objects. No movement analysis system is known to allow evaluation of the control of forces produced during the manipulation of objects in everyday tasks. The potential market is large because neurological and psychological clinics, motor control research laboratories, government laboratories, educational testing services, rehabilitation centers, health insurance companies, and environmental testing laboratories are in need of such an assessment device. The novelty of our system is that it combines portability, flexibility, and accurate analysis methods based on recent findings in motor research. PROPOSED COMMERCIAL APPLICATIONS: The proposed movement analysis system quantifies force control and regulation. The assessment of movement impairments can be made more objective by evaluating how a given individual controls and regulates force during prehension movements when grip and load forces form a stable coordination pattern. No similar movement analysis system is on the market. The potential market consists of neurological and psychological clinics, motor control research laboratories, educational testing services, rehabilitation centers, and health insurance companies. |
0.904 |
2003 | Alberts, Jay L | R03Activity Code Description: To provide research support specifically limited in time and amount for studies in categorical program areas. Small grants provide flexibility for initiating studies which are generally for preliminary short-term projects and are non-renewable. |
Deep Brain Stimulation and Force Control in Parkinson's @ Georgia Institute of Technology The proposed research is related to Research Objective #11, Sensory and Motor Processing. Parkinson's disease (PD) is a progressive age-related neurodegenerative disorder whose pathological hallmark is the degeneration of dopaminergic neurons in the substantia nigra pars compacta and depletion of striatal dopamine levels. As a result of this degeneration, neuronal activity of the primary output structure of the basal ganglia, the internal segment of the globus pallisus (GPi), is increased in an aberrant fashion and development of the cardinal motor features of PD, including akinesia, bradykinesia, tremor, and/or rigidity, occurs. Although its mechanisms remain unclear, deep brain stimulation (DBS) of the GPi or subthalamic nucleus (STN) provides a promising surgical approach in the alleviation of parkinsonian motor signs. However, the relative novelty of DBS has precluded the systematic investigation of the effects of DBS in GPi or STN on motor performance in advanced PD patients. The primary goal of this project is to determine effects of DBS in STN or GPi on force control in advanced PD patients. It is hypothesized that basal ganglia dysfunction, as exhibited in advanced PD, adversely affects PD patients ability to precisely control forces produced by the digits. Furthermore, it is hypothesized that DBS of GPi or STN improves force control capabilities of PD patients by "normalizing" neuronal output from GPi. Patients will use a precision grip (thumb and index finger only) to perform a force-tracking task in which they will be required to produce and maintain a wide range of target forces (5-50% of maximum). Data will be collected from 10 STN and 10 GPi patients prior to stimulator implantation. Approximately six months after stimulator impantation, patients will perform the same force-track task. Force (kinetic) and clinical measures will be used to determine the changes in force control and overall motor function. Data collected in this study will expand our understanding of the role of the basal ganglia in force control. Upon completion of this project, recommendations will be made regarding the optimal stimulation site for improving the control of digit forces of in advanced PD patients. The results of these studies may improve the treatment of advanced PD. |
0.91 |
2004 — 2005 | Alberts, Jay L | R21Activity Code Description: To encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.) |
Air Muscle and Task Practice in Upper Limb Stroke Rehab @ Georgia Institute of Technology DESCRIPTION (provided by applicant): The proposed project addresses the issues of motor function and quality of life in patients with stroke as described in NIH PA-02-111. Many patients who have sustained strokes are unable to effectively use their hemiparetic upper extremity. Limited mobility in the performance of daily activities, such as eating or dressing, adversely affects their quality of life and compromises independence. Rehabilitation techniques engaging the hemiparetic limb in repetitive task practice (RTP) may improve upper extremity function and quality of life in patients with stroke, but costs limit the number of patients that can utilize this type of therapy. Advances in microprocessor design and function make the use of an assistive device as an adjunct to RTP plausible. An innovative assistive repetitive motion (ARM) device using an "air muscle" has been developed specifically for the rehabilitation of the hemiparetic upper extremity. The primary aim of the proposed study is to collect pilot data to estimate the clinical effectiveness of using the ARM device in conjunction with RTP to improve upper extremity motor function and the quality of life of patients with stroke. Twenty sub-acute (3 to 9 mos. post-stoke) patients will be randomized to one of three groups: ARM only, RTP only or RTP + ARM group. The ARM group will use the ARM for four hours per day for 15 days. The RTP group will receive 15 days (4 hours per day) of intensive one-on-one RTP therapy. The ARM + RTP group will use the ARM device for 2 hours per day and receive 2 hours of intensive RTP per day for 15 days. Clinical motor function and quality of life measures will be taken before and after the interventions and two months later. We hypothesize that the ARM + RTP group will exhibit greater improvements in motor function and quality of life measures than the ARM or RTP only groups. Gathering quantitative motor (kinematic and kinetic) and imaging (fMRI) data from a subset of patients in each group to examine potential mechanisms contributing to improved motor function constitute unique addenda to this study. The results from this project will provide valuable data as a pre-requisite for submission of a multi-year R01 randomized clinical trial to determine the efficacy of using an assistive device, such as the ARM, as an adjunct to RTP. This project has the potential to increase the availability of effective rehabilitation techniques to patients with stroke. |
0.91 |
2009 — 2010 | Alberts, Jay L Vitek, Jerrold L [⬀] |
R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
@ University of Minnesota The overall aim of this project is to clarify the relationship between neuronal activity in the internal segment of the globus pallidus (GPi) and the development, phenotypic distribution and severity of dystonic movements in patients with primary generalized (PGD) and cervical dystonia (CD). Three fundamental questions will be addressed: 1) What are the physiological characteristics of neurons in the basal ganglia in patients with PGD and CD? 2) Is there a relationship between those physiological characteristics ( e.g. mean discharge rate, somatosensory response properties, or the number of cells with bursting or power at low oscillatory frequencies) and clinical measures of dystonia severity (Burke Fahn Marsden Dystonia Rating Scale for PGD and Toronto Western Spasmodic Torticollis Rating Scale for CD)? and 3) Is there a difference in the relative proportion and distribution of neurons in the GPi that demonstrate these dystonic characteristics between patients with PGD and those with CD? Neural and force control data will be gathered simultaneously in the operating room during microelectrode mapping of the GPi as part of deep brain stimulation surgery. As part of this two-year project, neuronal, EMG and force control data will be collected from 18 (9 PGD and 9 CD) dystonia patients. Specific Aims 1 and 2 are focused on determining the relationship between neuronal activity (i.e. mean discharge rate, pattern, oscillatory activity and somatosensory response properties) within the GPi and the severity of PGD and CD, respectively. The final phase of Aims 1 and 2 will be to compare the neural activity within the GPi in patients with PGD and CD. This comparison will allow us to determine if PGD and CD patients have common alterations in neural activity or if each type of dystonia has its own unique'pathophysiology. In Specific Aim 3, patients will perform a force-tracking motor task during the recording of neural activity within GPi. Motor performance will be objectively quantified using biomechanical measures. The simultaneous collection of neural and motor data is unique and will clarify the relationship between neuronal activity within the GPi of PGD and CD patients and their specific impairments in the control of muscle forces, in particular the scaling and focusing of force. Identifying specific physiological characteristics associated with dystonia, determining the spatial segregation of affected neurons in PGD and CD and understanding the specific motor impairments of each will refine current surgical strategies and may lead to new surgical approaches to relieve dystonic symptoms. |
0.952 |
2010 | Alberts, Jay L Koeneman, James B Wolf, Steven L. |
RC3Activity Code Description: To accelerate the transition of NIH-supported research innovations and technologies toward the development of products or services that will improve human health, through grants that may advance the mission of NIH and its Institutes and Centers (ICs), and create significant value and economic stimulus or, advance the research enterprise in a way that could stimulate future growth and investments and advance public health and health care delivery. This activity code is intended to support research and development (R&D) specifically targeted at activities that can help address the funding gap between promising R&D and transitioning to the market, often called the 'Valley of Death' by contributing the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end; to foster partnerships among a variety of research and development (R&D) collaborators working toward these aims. Awards are made only to U.S.-owned, for-profit enterprises doing a majority of its business in the United States. RC3 applications may be given funding priority if the applicant organization is associated with an enterprise that is of small size (e.g., 500 or fewer employees), and/or of limited resources, such as an early-stage company, and/or one positioned for receiving funding or in-kind support from a third-party investor and/or strategic partner. The RC3 SPAN program is not intended to support 'upstream' R&D for doing feasibility testing of an innovative idea or to conduct early-stage R&D as an extension of such ideas. (Projects such as these should be submitted under the NIH SBIR/STTR programs.) |
An Innovative Home Stroke Rehabilitation and Monitoring System @ Kinetic Muscles, Inc. DESCRIPTION (provided by applicant): This proposal demonstrates a novel healthcare delivery system that has the potential to significantly advance stroke rehabilitation monitoring and therapy. The broad, long-term objective is to provide accessible, affordable stroke care for people in rural and underserved areas. A major public health issue is the variability in the quality and quantity of treatment that stroke survivors receive based on their proximity to major metropolitan medical centers. This proposal evaluates a system of stroke patient monitoring and delivery of state-of-the-art stroke therapy for that is accessible for rural residents. This comprehensive rehabilitation delivery system utilizes Web-based platforms for storage and retrieval of patient information in conjunction with easy-to-use robot therapy devices that can be remotely monitored. Collected data are automatically entered into the system and sent to a data center (transparent to the user), where the information is monitored by a clinician through a secure website. To demonstrate the functionality of the system, an existing user-friendly home-compatible stroke therapy robotic device is utilized. A randomized, controlled, multisite clinical trial is designed to evaluate this combination of controlled rehabilitation therapy for stroke survivors with telehealth components. The model can be generalized in the future with the use of other home-based therapy and monitoring devices as needed for a specific patient. Fostering effective home treatments through the use of these devices will help determine the difference between functional independence and nursing home placement. The clinical trial will enroll 96 stroke patients and treat them at home for three months. These important considerations combine contemporary technology for service delivery and the potential for cost-savings. In a relatively short time, these advances will have a major beneficial impact on the delivery of stroke therapy to millions of rural stroke survivors. Kinetic Muscles, Inc. is an emerging company developing state-of-the-art therapy devices to fundamentally improve rehabilitation for people with neurologic injury such as stroke or traumatic brain injury (TBI). As an early stage medical device company, we regularly seek private funding to support growth objectives. Funding of this proposal would not only allow KMI to retain and add four full-time research and development personnel but would also facilitate additional funding from the private investment community to accelerate market deployment of innovative telerehabilitation therapy. This strategy has the realistic capability to provide a new level of accessible, affordable rehabilitative care for stroke patients. It is estimated that this current proposal will also create or retain four jobs between the Cleveland Clinic and Emory University. PUBLIC HEALTH RELEVANCE: The purpose of this research is to evaluate a therapy delivery system for stroke patients that provide accessible, affordable stroke care. User-friendly home therapy robots and a telerehabilitation system are combined to monitor and provide therapy that is accessible for patients in rural and underserved locations. |
0.906 |